Sourcing gold and mineral-infused Ayurvedic tablets requires verifying AYUSH licences, reviewing certificates of analysis for Bhasma-specific tests and.
Sourcing gold and mineral-infused Ayurvedic tablets for a branded product line or wholesale distribution requires structured due diligence. These products sit within the Ras Shastra category, are regulated as Ayurvedic drugs under the Drugs and Cosmetics Act, and carry quality risks that can affect both regulatory compliance and market reputation if the wrong supplier is selected.
Gold and mineral-infused Ayurvedic tablets, which include formulations containing Swarna Bhasma, other Bhasma preparations or mineral Shodhit Dravya, are among the more complex products in the Ayurvedic manufacturing landscape. The input materials require classical processing through validated Shodhana and Marana steps before they are suitable for use in finished formulations.
Because the inputs are costly and the processing steps are technically demanding, these products are more susceptible to adulteration or shortcut manufacturing than simpler herbal preparations. A buyer who does not apply rigorous due diligence may receive a product that does not meet the pharmacopoeial standards required under their own AYUSH manufacturing licence or that does not carry adequate documentation for the markets they supply.
The regulatory framework under Schedule T GMP requires that Ayurvedic drug manufacturers source inputs from documented, licensed suppliers. A brand owner or distributor sourcing gold and mineral tablets for resale is directly exposed to the quality and compliance status of their upstream supplier.
The most fundamental check is confirming that the supplier holds an AYUSH manufacturing licence issued by the relevant state licensing authority. This licence specifies the product categories and specific formulations the manufacturer is authorised to produce.
For gold and mineral tablets, the relevant licence categories include Ras Rasayana, Bhasma-Pishti and in some cases Vati, depending on the dosage form. Raasa Ayurveda holds AYUSH licence A-4177/2009 covering multiple categories including Ras Rasayana (53 formulations) and Bhasma-Pishti (35 formulations), with manufacturing at its Kanpur facility under GMP certificate D-5755/09.
Ask the supplier to share a copy of their current AYUSH licence and GMP certificate. Cross-check that the formulations you need are within the licence scope, not merely similar or related products.
In addition to the AYUSH licence, confirm whether the supplier holds FSSAI registration if any of their products cross into the food supplement category, though most classical Ras Rasayana formulations are regulated under the Drugs and Cosmetics Act rather than FSSAI.
The certificate of analysis is the primary quality document for each batch of gold and mineral tablets. A thorough evaluation of this document is one of the most important steps in the due diligence process.
For formulations containing Swarna Bhasma, the certificate should cover: the classical quality tests specific to Bhasma (Nishchandratwa, Rekhapurnata and Varitara where applicable), heavy metal profile against pharmacopoeial limits, loss on ignition, total ash and microbial limits including total plate count and absence of specified pathogens.
For mineral-based tablets containing Shodhit Dravya such as Shodhit Shilajit or Shodhit Guggulu, the relevant tests depend on the specific material but should include at minimum heavy metals, moisture and microbial parameters.
Verify that the certificate identifies the testing laboratory. Under GMP, testing can be performed in-house at a qualified laboratory or at an external accredited facility. For export-oriented buyers, third-party accredited laboratory results may be required by the importing country. Raasa Ayurveda provides a certificate of analysis with every consignment of gold-coated items and compound Ras Rasayana tablets.
Packaging for gold and mineral tablets must meet the requirements of the Drugs and Cosmetics Act for Ayurvedic drug labelling. The label must carry the AYUSH licence number, the batch number, the date of manufacture, the expiry or best-before date, the net content and the name and address of the manufacturing licence holder.
For buyers who will resell under their own brand, the labelling arrangement must be clarified with the manufacturer in advance. The contract manufacturer must hold a manufacturing licence that allows production for a third-party label (loan licence or contract manufacturing arrangement). The label must still carry the licence holder's details alongside the brand owner's name.
For bulk supply in larger quantities, packaging options typically include bulk HDPE containers, strip packaging or bottle formats. The choice affects shelf life, handling requirements and the presentation suitable for the buyer's market. Agree on packaging specifications before the first order to avoid reformatting costs later.
A GMP certified manufacturer must maintain batch manufacturing records for every production run. These records document raw material receipt, processing steps, in-process checks, finishing tests and release authorisation. A buyer conducting meaningful due diligence should ask to review the format of these records, even if the specific batch data is confidential.
Ask also whether the manufacturer can provide a statement of the classical text and process reference followed for the specific formulation. For Shastrayoga formulations, the Ayurvedic Formulary of India or the relevant classical text defines the composition and process. A manufacturer who cannot identify the classical reference for their product is not producing a classical Shastrayoga formulation regardless of the label.
For buyers sourcing for contract manufacturing of proprietary formulations that incorporate gold or mineral inputs, an additional discussion is needed about the specification for the custom formulation and the regulatory pathway required.
No buyer of gold or mineral Ayurvedic tablets should place a first bulk order without receiving and evaluating a sample. A sample should be accompanied by its own certificate of analysis so the buyer can compare the supplied material's test results against the specification before committing to volume.
Where possible, the buyer should conduct at least a basic verification of the sample in their own facility or through a third-party laboratory. At minimum, confirm the physical description, tablet weight uniformity and the absence of foreign matter. For high-value formulations containing gold, a simple spectroscopic check of elemental content provides an additional layer of verification.
Raasa Ayurveda provides samples before bulk orders as standard practice, with a certificate of analysis for each sample batch. To begin sourcing discussions for gold and mineral Ayurvedic tablets from Kanpur, contact the team at +91 9415128217 or write to raasaayurveda@gmail.com.
Relevant categories include Ras Rasayana and Bhasma-Pishti, and in some cases Vati depending on the dosage form. The licence must explicitly list the formulations the manufacturer is authorised to produce. Request a copy of the current licence and verify the specific formulations fall within its scope before placing any order.
Yes, through a contract manufacturing arrangement where Raasa Ayurveda manufactures the product and the buyer brands it under their own label. The labelling must comply with Drugs and Cosmetics Act requirements, including the AYUSH licence holder's details. Packaging and labelling terms are agreed before the first production run.
Formulations containing metals and minerals require verified heavy metal profiles because these materials, if not correctly processed through classical Shodhana and Marana, may contain elements at levels that do not meet pharmacopoeial limits. Export markets also scrutinise heavy metal data closely. A certificate of analysis from a GMP certified manufacturer should specify test results against applicable limits.
At minimum one sample with a full certificate of analysis is standard. For complex formulations or larger bulk commitments, requesting samples from two or three batches over a defined period provides better evidence of batch-to-batch consistency. Raasa Ayurveda accommodates sample requests before bulk orders as a standard part of the supply discussion.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.